SCHEMBL9135757

SCHEMBL9135757

COc1ccc(C(=O)C2CCCCCC2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.75
RAB9A P51151 2/20 0.75
POLB P06746 1/20 0.65
MAPK1 P28482 1/20 0.62
CHRM2 P08172 3/20 0.61
CHRM4 P08173 3/20 0.61
CHRM1 P11229 3/20 0.61
CHRM3 P20309 3/20 0.61
CASP3 P42574 1/20 0.60
SENP8 Q96LD8 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
SENP6 Q9GZR1 1/20 0.60
ALDH1A1 P00352 4/20 0.58
LMNA P02545 2/20 0.58
KDM2B Q8NHM5 4/20 0.58
SMN1; SMN2 Q16637 2/20 0.57
HSD11B1 P28845 1/20 0.57
MGLL Q99685 1/20 0.57
SRD5A2 P31213 1/20 0.57
KMT2A Q03164 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4611341 1.00 NPC1 (0.75) NPC1RAB9APOLBMAPK1CHRM2
SCHEMBL9136904 0.98 NPC1 (0.77) NPC1RAB9APOLBMAPK1CHRM2
SCHEMBL3367257 0.95 NPC1 (0.77) NPC1RAB9APOLBMAPK1CHRM2
SCHEMBL5350428 0.91 NPC1 (0.89) NPC1RAB9APOLBMAPK1CHRM2
SCHEMBL1148371 0.91 NPC1 (0.89) NPC1RAB9APOLBMAPK1CHRM2
SCHEMBL5350433 0.91 NPC1 (0.89) NPC1RAB9APOLBMAPK1CHRM2
Bicarbonate SCHEMBL11475731 0.87 NPC1 (0.83) NPC1RAB9APOLBMAPK1CHRM2
SCHEMBL1036177 0.84 MEN1 (0.61) NPC1RAB9APOLBCHRM2CHRM4
SCHEMBL1039910 0.84 MEN1 (0.61) NPC1RAB9APOLBCHRM2CHRM4
SCHEMBL4675008 0.83 NPC1 (0.71) NPC1RAB9APOLBMAPK1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5399698-A Lipoxygenase inhibitor intermediates BAYER AKTIENGESELLSCHAFT (DE) 1995-03-21 US disclosed
US-5231103-A Lipoxygenase inhibitors as antiinflammatory agents, antiasthma and cardiovascular disorders BAYER AKTIENGESELLSCHAFT (DE) 1993-07-27 US disclosed
EP-0525571-A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors BAYER AG (DE) 1993-02-03 EP disclosed